214 related articles for article (PubMed ID: 34934117)
1. Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites.
Williams TL; Strachan G; Macrae RGC; Kuc RE; Nyimanu D; Paterson AL; Sinha S; Maguire JJ; Davenport AP
Sci Rep; 2021 Dec; 11(1):24336. PubMed ID: 34934117
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
Elife; 2020 Oct; 9():. PubMed ID: 33103998
[TBL] [Abstract][Full Text] [Related]
3. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
4. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.
Suryamohan K; Diwanji D; Stawiski EW; Gupta R; Miersch S; Liu J; Chen C; Jiang YP; Fellouse FA; Sathirapongsasuti JF; Albers PK; Deepak T; Saberianfar R; Ratan A; Washburn G; Mis M; Santhosh D; Somasekar S; Hiranjith GH; Vargas D; Mohan S; Phalke S; Kuriakose B; Antony A; Ustav M; Schuster SC; Sidhu S; Junutula JR; Jura N; Seshagiri S
Commun Biol; 2021 Apr; 4(1):475. PubMed ID: 33846513
[TBL] [Abstract][Full Text] [Related]
5. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
6. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
Hussain M; Jabeen N; Raza F; Shabbir S; Baig AA; Amanullah A; Aziz B
J Med Virol; 2020 Sep; 92(9):1580-1586. PubMed ID: 32249956
[TBL] [Abstract][Full Text] [Related]
7. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
8. Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor.
Capraz T; Kienzl NF; Laurent E; Perthold JW; Föderl-Höbenreich E; Grünwald-Gruber C; Maresch D; Monteil V; Niederhöfer J; Wirnsberger G; Mirazimi A; Zatloukal K; Mach L; Penninger JM; Oostenbrink C; Stadlmann J
Elife; 2021 Dec; 10():. PubMed ID: 34927585
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.
Raghuvamsi PV; Tulsian NK; Samsudin F; Qian X; Purushotorman K; Yue G; Kozma MM; Hwa WY; Lescar J; Bond PJ; MacAry PA; Anand GS
Elife; 2021 Feb; 10():. PubMed ID: 33554856
[TBL] [Abstract][Full Text] [Related]
11. Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication.
Adams LE; Dinnon KH; Hou YJ; Sheahan TP; Heise MT; Baric RS
mBio; 2021 Mar; 12(2):. PubMed ID: 33727353
[TBL] [Abstract][Full Text] [Related]
12.
Lapaillerie D; Charlier C; Fernandes HS; Sousa SF; Lesbats P; Weigel P; Favereaux A; Guyonnet-Duperat V; Parissi V
Viruses; 2021 Feb; 13(3):. PubMed ID: 33669132
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
Brown EEF; Rezaei R; Jamieson TR; Dave J; Martin NT; Singaravelu R; Crupi MJF; Boulton S; Tucker S; Duong J; Poutou J; Pelin A; Yasavoli-Sharahi H; Taha Z; Arulanandam R; Surendran A; Ghahremani M; Austin B; Matar C; Diallo JS; Bell JC; Ilkow CS; Azad T
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668756
[TBL] [Abstract][Full Text] [Related]
14. Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective.
Wei Y; Aris P; Farookhi H; Xia X
Sci Rep; 2021 Jan; 11(1):1702. PubMed ID: 33462320
[TBL] [Abstract][Full Text] [Related]
15. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae.
Luan J; Jin X; Lu Y; Zhang L
J Med Virol; 2020 Sep; 92(9):1649-1656. PubMed ID: 32239522
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
Dakal TC
Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
[TBL] [Abstract][Full Text] [Related]
18. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.
Onabajo OO; Banday AR; Stanifer ML; Yan W; Obajemu A; Santer DM; Florez-Vargas O; Piontkivska H; Vargas JM; Ring TJ; Kee C; Doldan P; Tyrrell DL; Mendoza JL; Boulant S; Prokunina-Olsson L
Nat Genet; 2020 Dec; 52(12):1283-1293. PubMed ID: 33077916
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
20. ACE2 models of frequently contacted animals provide clues of their SARS-CoV-2 S protein affinity and viral susceptibility.
Ma C; Gong C
J Med Virol; 2021 Jul; 93(7):4469-4479. PubMed ID: 33755203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
